文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Are antibodies directed against amyloid-β (Aβ) oligomers the last call for the Aβ hypothesis of Alzheimer's disease?

作者信息

Panza Francesco, Lozupone Madia, Dibello Vittorio, Greco Antonio, Daniele Antonio, Seripa Davide, Logroscino Giancarlo, Imbimbo Bruno P

机构信息

Neurodegenerative Disease Unit, Department of Basic Medicine, Neuroscience, & Sense Organs, University of Bari Aldo Moro, Bari, Italy.

Department of ClinicalResearch in Neurology, Center for Neurodegenerative Diseases and the AgingBrain, University of Bari "Aldo Moro", "Pia Fondazione Cardinale G. Panico", Tricase, Lecce, Italy.

出版信息

Immunotherapy. 2019 Jan;11(1):3-6. doi: 10.2217/imt-2018-0119.

DOI:10.2217/imt-2018-0119
PMID:30702009
Abstract
摘要

相似文献

[1]
Are antibodies directed against amyloid-β (Aβ) oligomers the last call for the Aβ hypothesis of Alzheimer's disease?

Immunotherapy. 2019-1

[2]
Treatments for Alzheimer's disease emerge.

Science. 2021-8-6

[3]
Alzheimer's therapy: a BACE in the hand?

Nat Med. 2011-8-4

[4]
SAR228810: an antibody for protofibrillar amyloid β peptide designed to reduce the risk of amyloid-related imaging abnormalities (ARIA).

Alzheimers Res Ther. 2018-11-28

[5]
Amyloid beta peptide immunotherapy in Alzheimer disease.

Rev Neurol (Paris). 2014-12

[6]
Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?

Curr Opin Psychiatry. 2014-3

[7]
A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice.

Mol Neurodegener. 2015-9-3

[8]
Structural aspects of Alzheimer's disease immunotherapy targeted against amyloid-beta peptide.

Bratisl Lek Listy. 2018

[9]
Targeting beta-amyloid pathology in Alzheimer's disease with Abeta immunotherapy.

Neurotherapeutics. 2008-7

[10]
The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy.

EBioMedicine. 2016-4

引用本文的文献

[1]
The role of probiotics, prebiotics, and postbiotics: cellular and molecular pathways activated on glial cells in Alzheimer's disease.

Front Neurosci. 2025-6-25

[2]
Noninvasive Treatment of Alzheimer's Disease with Scintillating Nanotubes.

Adv Healthc Mater. 2023-12

[3]
Guilingji capsule for Alzheimer's disease: secondary analysis of a randomized non-inferiority controlled trial.

J Tradit Chin Med. 2023-10

[4]
Neuropathology of the Alzheimer's continuum: an update.

Free Neuropathol. 2020-11-11

[5]
Discoveries and future significance of research into amyloid-beta/α7-containing nicotinic acetylcholine receptor (nAChR) interactions.

Pharmacol Res. 2023-5

[6]
The Vascular-Immune Hypothesis of Alzheimer's Disease.

Biomedicines. 2023-1-30

[7]
Early diagnosis and treatment of Alzheimer's disease by targeting toxic soluble Aβ oligomers.

Proc Natl Acad Sci U S A. 2022-12-6

[8]
Deregulation of Mitochondrial Calcium Handling Due to Presenilin Loss Disrupts Redox Homeostasis and Promotes Neuronal Dysfunction.

Antioxidants (Basel). 2022-8-24

[9]
A Historical Review of Brain Drug Delivery.

Pharmaceutics. 2022-6-16

[10]
ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer's Disease.

Front Neurosci. 2022-4-26

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索